| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1026256245 |
| P356 | DOI | 10.1007/S00384-015-2289-4 |
| P8608 | Fatcat ID | release_ykb6iwlblng45mwojgxl3oskse |
| P932 | PMC publication ID | 4575375 |
| P698 | PubMed publication ID | 26198994 |
| P5875 | ResearchGate publication ID | 280392488 |
| P50 | author | Philippe Lambin | Q28320422 |
| P2093 | author name string | Rogier J de Ridder | |
| Emile N van Lin | |||
| Lien Van De Voorde | |||
| Ben G L Vanneste | |||
| Evert J Van Limbergen | |||
| P2860 | cites work | Radiobiology of tissue reactions | Q87007919 |
| Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy | Q87279960 | ||
| A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy | Q87710697 | ||
| A study on the etiology of cirrhosis of liver in adults living in the Hills of Himachal Pradesh, India | Q88396459 | ||
| Genetics and genomics of radiotherapy toxicity: towards prediction | Q21183971 | ||
| Hyperbaric oxygen therapy for late radiation tissue injury | Q24197835 | ||
| Application of 10 percent formalin for the treatment of radiation-induced hemorrhagic proctitis | Q28201599 | ||
| Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis | Q28204192 | ||
| Argon plasma coagulation for radiation proctitis | Q28219253 | ||
| Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer | Q28252307 | ||
| Management of radiation proctitis | Q28281459 | ||
| Prostatourethral-rectal fistula after prostate brachytherapy | Q30306333 | ||
| Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study. | Q30597673 | ||
| Treatment of radiation proctitis with argon plasma coagulation | Q30653417 | ||
| Argon plasma coagulation is an effective treatment for refractory hemorrhagic radiation proctitis | Q30777981 | ||
| Efficacy and complications of argon plasma coagulation for hematochezia related to radiation proctopathy | Q30784711 | ||
| Endoscopic therapy for radiation proctitis-induced hemorrhage in patients with prostatic carcinoma using argon plasma coagulator application | Q30833752 | ||
| Efficacy of argon plasma coagulation compared to topical formalin application for chronic radiation proctopathy | Q30841424 | ||
| KTP laser therapy for bleeding from chronic radiation proctopathy | Q30915483 | ||
| Confocal laser endomicroscopy in the "in vivo" histological diagnosis of the gastrointestinal tract | Q30975698 | ||
| High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients | Q31097302 | ||
| Argon plasma coagulation as first-line treatment for chronic radiation proctopathy | Q31113434 | ||
| Radiation-induced proctosigmoiditis | Q57071875 | ||
| Human Collagen Injections to Reduce Rectal Dose During Radiotherapy | Q57095566 | ||
| Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer | Q57095570 | ||
| Is It Time to Tailor the Prediction of Radio-Induced Toxicity in Prostate Cancer Patients? Building the First Set of Nomograms for Late Rectal Syndrome | Q59708583 | ||
| Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy | Q62269588 | ||
| A simple and effective treatment for hemorrhagic radiation proctitis using formalin | Q70541631 | ||
| A new concept in the treatment of osteoradionecrosis | Q70903526 | ||
| Application of formaldehyde for treatment of hemorrhagic radiation-induced proctitis | Q71514545 | ||
| Intrarectal formalin application, an effective treatment for grade III haemorrhagic radiation proctitis | Q71539712 | ||
| Colonoscopy in radiation colitis | Q72076966 | ||
| Bowel explosion with colonic perforation during argon plasma coagulation for hemorrhagic radiation-induced proctitis | Q73068501 | ||
| Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy | Q73219072 | ||
| [Long term results of treatment of hemorrhagic radiation proctitis by argon plasma coagulation] | Q73618278 | ||
| Complications following formalin installation in the treatment of radiation induced proctitis | Q73899627 | ||
| Metronidazole in the treatment of chronic radiation proctitis: clinical trial | Q74233196 | ||
| Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension | Q77425586 | ||
| Prospective evaluation of formalin therapy for radiation proctitis | Q77872297 | ||
| The surgical management of colorectal complications from irradiation for carcinoma of the cervix | Q77907254 | ||
| Long-term outcome of argon plasma coagulation therapy for bleeding caused by chronic radiation proctopathy | Q79365854 | ||
| Frequency and surgical management of chronic complications related to pelvic radiation | Q80523832 | ||
| Argon plasma coagulation in chronic radiation proctitis: Postgate et al | Q80695896 | ||
| Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients | Q80814006 | ||
| Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up | Q80876623 | ||
| Formalin for haemorrhagic radiation-induced proctitis | Q84437264 | ||
| Application of anorectal sparing devices in prostate radiotherapy | Q86328197 | ||
| Formalin dab, the effective way of treating haemorrhagic radiation proctitis: a randomized trial from a tertiary care hospital in South India. | Q50962738 | ||
| Formalin application in the treatment of chronic radiation-induced hemorrhagic proctitis--an effective but not risk-free procedure: a prospective study of 33 patients. | Q51223416 | ||
| Intrarectal application of formalin for chronic radiation proctitis: a simple, cheap and effective treatment. | Q51541090 | ||
| Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer. | Q51769274 | ||
| Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT. | Q51895523 | ||
| Management of radiotherapy induced rectourethral fistula. | Q51947886 | ||
| Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. | Q52068684 | ||
| Accuracy and reliability of the endoscopic classification of chronic radiation-induced proctopathy using a novel grading method. | Q52970957 | ||
| Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy. | Q53152503 | ||
| How patients manage gastrointestinal symptoms after pelvic radiotherapy | Q53365962 | ||
| Two percent formalin retention enemas for hemorrhagic radiation proctitis: a preliminary report. | Q40448484 | ||
| A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy. | Q40448564 | ||
| Frequency and outcomes of rectal ulcers during argon plasma coagulation for chronic radiation-induced proctopathy | Q40562465 | ||
| Inflammatory bowel disease revisited: newer drugs | Q41208857 | ||
| Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients | Q41266094 | ||
| Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate | Q41778177 | ||
| A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes | Q42116748 | ||
| A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. | Q42208433 | ||
| Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma | Q42621722 | ||
| Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial | Q42683439 | ||
| Late progress of radiation-induced proctitis | Q43525789 | ||
| Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. | Q43584410 | ||
| Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial | Q44223616 | ||
| Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial | Q44493061 | ||
| Time course and predictors of symptoms after primary prostate cancer therapy | Q44674450 | ||
| Spacers in radiotherapy treatment of prostate cancer: is reduction of toxicity cost-effective? | Q44983881 | ||
| Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: A double-blind, randomized trial. | Q45133680 | ||
| The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors | Q45202891 | ||
| Argon plasma coagulation therapy versus topical formalin for intractable rectal bleeding and anorectal dysfunction after radiation therapy for prostate carcinoma. | Q45992890 | ||
| Argon plasma coagulation has a long-lasting therapeutic effect in patients with chronic radiation proctitis. | Q46013081 | ||
| Chronic radiation-induced proctitis: the 4 % formalin application as non-surgical treatment. | Q46393374 | ||
| Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients | Q46649727 | ||
| Dose escalation of amifostine for radioprotection during pelvic accelerated radiotherapy | Q47696721 | ||
| Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial | Q48063074 | ||
| Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial | Q48162758 | ||
| Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity. | Q49046798 | ||
| Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control | Q49064521 | ||
| Effective use of argon plasma coagulation in the treatment of severe radiation proctitis. | Q32048109 | ||
| Treatment of radiation proctitis | Q33295476 | ||
| Surgical management of intestinal radiation injury | Q33400198 | ||
| The clinical needs of patients with chronic gastrointestinal symptoms after pelvic radiotherapy | Q33437737 | ||
| Relationship of oxygen dose to angiogenesis induction in irradiated tissue | Q33453643 | ||
| Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers | Q33459118 | ||
| Efficacy and safety of single-session argon plasma coagulation in the management of chronic radiation proctitis | Q33584531 | ||
| The pitfalls of treating anorectal conditions after radiotherapy for prostate cancer | Q34257619 | ||
| Technology of argon plasma coagulation with particular regard to endoscopic applications | Q34333566 | ||
| Chronic radiation proctitis: issues surrounding delayed bowel dysfunction post-pelvic radiotherapy and an update on medical treatment | Q34409227 | ||
| Endoscopic and medical therapy for chronic radiation proctopathy: a systematic review | Q34410738 | ||
| Formalin instillation for refractory radiation-induced hemorrhagic proctitis | Q34610258 | ||
| Systematic review: anal and rectal changes after radiotherapy for prostate cancer | Q35024218 | ||
| A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach | Q35036339 | ||
| Effects of prostate-rectum separation on rectal dose from external beam radiotherapy | Q35047440 | ||
| Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist | Q35112183 | ||
| Treatment of hemorrhagic radiation proctitis with 4 percent formalin | Q35147751 | ||
| Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score | Q36495325 | ||
| Gastrointestinal radiation injury: symptoms, risk factors and mechanisms | Q36541173 | ||
| Gastrointestinal radiation injury: prevention and treatment | Q36541213 | ||
| Radiation proctopathy in the treatment of prostate cancer | Q36663280 | ||
| Formalin instillation for refractory radiation-induced hemorrhagic proctitis. Report of 16 patients | Q36797894 | ||
| Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients | Q36988575 | ||
| Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management | Q37402652 | ||
| Chronic radiation enteritis | Q37629333 | ||
| Proton beam and prostate cancer: An evolving debate | Q38177807 | ||
| Optimization of radiation therapy techniques for prostate cancer with prostate-rectum spacers: a systematic review | Q38259067 | ||
| Particle radiotherapy for prostate cancer | Q38259506 | ||
| Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects | Q38291393 | ||
| Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis | Q38357630 | ||
| A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers | Q38357722 | ||
| Spacer application for prostate cancer radiation therapy | Q39198013 | ||
| Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer | Q39367376 | ||
| Radiation proctitis: current strategies in management | Q39448990 | ||
| Rectal bleeding after radiation therapy for prostate cancer: endoscopic evaluation | Q39548560 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| proctitis | Q941770 | ||
| Radiation proctitis | Q7280363 | ||
| radiation sickness | Q21652028 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1293-303 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | International Journal of Colorectal Disease | Q15758189 |
| P1476 | title | Chronic radiation proctitis: tricks to prevent and treat | |
| P478 | volume | 30 |
| Q89869781 | A biodegradable rectal balloon implant to protect the rectum during prostate cancer radiotherapy for a patient with active Crohn's disease |
| Q59136739 | Ano-rectal wall dose-surface maps localize the dosimetric benefit of hydrogel rectum spacers in prostate cancer radiotherapy |
| Q47309995 | Correlation between Disease Activity and Endorectal Ultrasound Findings of Chronic Radiation Proctitis |
| Q64979333 | Developing a multivariable normal tissue complication probability model to predict late rectal bleeding following intensity-modulated radiation therapy. |
| Q50077685 | Dynamics of rectal balloon implant shrinkage in prostate VMAT : Influence on anorectal dose and late rectal complication risk |
| Q48353113 | Efficacy of hyperbaric oxygen therapy in patients with radiation-induced rectal ulcers: Report of five cases |
| Q28076526 | Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleeding |
| Q48054266 | Endoscopic diode laser therapy for chronic radiation proctitis |
| Q38880103 | Implantation of a biodegradable rectum balloon implant: tips, Tricks and Pitfalls |
| Q90720710 | Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity |
| Q55330090 | Pelvic Catastrophe after Elastic Band Ligation in an Irradiated Rectum. |
| Q37578562 | Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know? |
| Q92723420 | Rectal wall dose-volume effect of pre- or post KUSHEN Ningjiaos relationship with 3D brachytherapy in cervical cancer patients |
| Q50100724 | Role of Angiogenesis in Chronic Radiation Proctitis: New Evidence Favoring Inhibition of Angiogenesis Ex Vivo |
| Q47138314 | What pelvic radiation disease symptoms are experienced by patients receiving external beam radiotherapy and a high-dose-rate brachytherapy boost for prostate cancer? |
Search more.